ABSTRACT
Background: Uterine scar dehiscence is a complication in which scar tissue remaining from previous C-section is disrupted and separated. Its incidence ranges between 0.2%-4.3% of all pregnancies with previous caesarean. It is asymptomatic in 48% of patients and thus is a serious complication because if not predicted it can lead to uterine rupture.Methods: Patients included in the study were of previous caesarean who were taken for repeat caesarean and scar dehiscence was not predicted preoperatively but seen intra-operatively. History, symptoms, signs and radiological investigations were interpreted to find out single or multiple factors responsible for scar dehiscence.Results: Incidence of scar dehiscence was found to be 8.3% .Scar dehiscence was detected in 55% of cases who were gravida 3 and above, all patients with intraoperative scar tenderness, 35% of patients with scar thickness ˂2mm, 70% cases with POG 37-40 weeks, 65% of patients with interpregnancy interval˂18 months,86.6% of patients with scar dehiscence had baby birth weight ˃3kg.Conclusions: Authors concluded that a single factor which has maximum predictive value for scar dehiscence is scar tenderness.
ABSTRACT
Uterine fibroids are a very common finding in women of reproductive age. The majority of fibroids do not change their size during pregnancy, but one-third may grow in the first trimester. Although the data are conflicting and most women with fibroids have uneventful pregnancies, the weight of evidence in the literature suggests that uterine fibroids are associated with an increased rate of spontaneous miscarriage, preterm labor, placenta abruption, malpresentation, labor dystocia, cesarean delivery, and postpartum hemorrhage.
ABSTRACT
Background:Oral contraceptives can induce changes in lipid, lipoprotein and carbohydrate metabolism. This study is done to find out basal lipid profile in females of reproductive age group using sequential hormone therapy and with low dose estrogen combinations pills; and to study the changes in lipid profile after 3 months use of sequential hormone therapy and with low dose estrogen combination pills. Methods: Total 40 females were taken of 18-40years of reproductive age group ,subjects were divided into two groups. Group A: 20 females were subjected to sequential hormones therapy. Group B: 20 females were subjected to combined oral contraceptive pill “Mala N”. Results: In Group A there was significant rise in serum cholesterol, serum TGs ,LDL, VLDL levels and LDL:HDL ratio. HDL shows fall in there levels. In Group B there was no significant change in all lipid parameters. Conclusion: There is substantial degree of metabolic changes in lipid lipoprotein profile in females with use of sequential hormones .With use of low dose estrogen and progesterone pills, there is no such deleterious effect on lipid profile and so it can be used for prolonged period. As the indications of use of sequential hormones in females of reproductive age group are now increasing in gynecological practice it would be advisable to decrease the dose of estrogen to avoid its effects on lipid profile